Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1985-03-28
1987-05-12
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 3116
Patent
active
046650989
ABSTRACT:
A dosage of N-(4-hydroxyphenyl)retinamide, also known as fenretimide, of the following formula: ##STR1## with increased bioavailability comprising corn oil and a non-ionic surfactant. The formulation if useful in the treatment of breast or bladder cancer, psoriasis and acne.
REFERENCES:
patent: 4190594 (1980-02-01), Gander et al.
patent: 4323581 (1982-04-01), Gander
"Pharmacokinetics of N-(4-Hydroxyphenyl)-all-trans-Retinamide in Rats", Brian N. Swanson et al., Laboratory of Chemoprevention, National Cancer Institute, vol. 8, No. 3, (1979), pp. 168-172.
"N-(4-Hydroxyphenyl)retinamide, A New Retinoid for Prevention of Breast Cancer in Rat", Richard C. Moon et al., IIT Research Institute, Chicago, IL, vol. 39, (1979), pp. 1339-1346.
"Biopharmaceutics of Drugs Administered in Lipid-Containing Dosage Forms I; GI Absorption of Griseofulvin from an Oil-in-Water Emulsion in the Rat", Philip J. Carrigan et al., Journal of Pharmaceutical Sciences, vol. 62, No. 9, (1973), pp. 1476-1479.
"The Theory and Practice of Industrial Pharmacy", Leon Lachman et al., Lea & Febiger, Philadelphia, (1970), pp. 359-384.
"Effect of Lipid Vehicles on the Oral Absorption of a Model Compound (DDT)", K. Palin et al., J. Pharm. Pharmacol., (1980), vol. 32, Supplement p. 62P.
"Hypotensive Action of Commercial Intravenous Amiodarone and Polysorbate 80 in Dogs", William B. Gough et al., Journal of Cardiovascular Pharmacology, vol. 4, p. 375, (1982).
"Communications, `Effect of Formulation on the Bioavailability of Retinol, D-.alpha.-Tocopherol and Riboflavine` ", N. E. Bateman et al., J. Pharm. Pharmacol., (1984), vol. 36, pp. 461-464.
Gibbs Irwin S.
Kotwal Pramod M.
Goldberg Jerome D.
Levy David J.
McNeilab Inc.
LandOfFree
Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide hav does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide hav, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide hav will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1802710